Healthcare / Health Information ServicesASX
$0.17
-0.02 (-8.33%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-8.5M · quality 76.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
19/100
F
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$145M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-345.4%
↓Gross Margin
63.9%
↑Debt/Equity
0.30
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+10.4%
FCF CAGR
—
FCF margin
-70.7%
FCF / Net income
0.67x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $12.0M · net income $-12.6M · FCF $-8.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $12.0M | $12.0M | $9.9M | $9.4M | $8.9M |
| Net Income | $-12.6M | $-12.6M | $-10.8M | $-8.9M | $-10.9M |
| EBITDA | $-10.5M | $-10.5M | $-10.1M | $-7.9M | $-10.1M |
| EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Gross Margin | 63.9% | 63.9% | 67.4% | 65.6% | 59.9% |
| Operating Margin | -96.4% | -96.4% | -120.1% | -94.3% | -144.1% |
| Net Margin | -104.9% | -104.9% | -109.5% | -95.1% | -121.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.30 | 0.30 | 0.09 | 0.10 | 0.24 |
| Current Ratio | 1.30 | 1.30 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-8.5M | $-8.5M | $-10.9M | $-7.8M | $-9.0M |
| Returns | |||||
| ROE | -345.4% | -345.4% | -81.8% | -97.8% | -481.7% |
| Valuation | |||||
| P/B | 34.64 | 34.64 | 15.50 | 15.46 | 22.68 |
| Growth & Yield | |||||
| Revenue Growth | 21.3% | 21.3% | 5.3% | 5.3% | — |
| EPS Growth | -4.4% | -4.4% | -3.9% | 24.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-38.9%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.02 → -0.02
Residual
-38.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.